Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision stamp on the page updated from v3.6.5 to v3.6.6, indicating a newer release. This appears to be a metadata/versioning update rather than a content change affecting the study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page. This change does not modify study data, eligibility criteria, or other substantive content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision line on the page updated from v3.6.3 to v3.6.4. This represents a minor update to the page's version information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a deployment/maintenance update to the ClinicalTrials.gov page. This change represents behind-the-scenes maintenance rather than modifications to study details or content.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a software version update for the page. No study content or data is changed by this update.SummaryDifference0.0%

- Check92 days agoChange DetectedA new note 'No longer looking for participants' was added, signaling that recruitment for the study is closed. The page also includes new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates to the Intervention/Treatment heading and the revision footer (Revision: v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.